Is a Surprise Coming for Astria Therapeutics (ATXS) This Earnings Season?

Published on 17 Nov 2023 on Zacks · via Yahoo Finance

Investors are always looking for stocks that are poised to beat at earnings season and Astria...

Read the rest of the article

Start tracking your investments with Statfolio

Key Insights Astria Therapeutics' estimated fair value is US$6.81 based on 2 Stage Free Cash Flow...

Simply Wall St. · via Yahoo Finance 22 Feb 2025

Investors interested in Medical stocks should always be looking to find the best-performing...

Zacks · via Yahoo Finance 17 Dec 2024

Astria Therapeutics Inc (NASDAQ:ATXS), a biopharmaceutical company focused on the discovery, deve...

GuruFocus.com via Yahoo Finance 4 Apr 2024

Key Insights Significantly high institutional ownership implies Astria Therapeutics' stock price ...

Simply Wall St. via Yahoo Finance 23 Mar 2024

Investors interested in Medical stocks should always be looking to find the best-performing compa...

Zacks via Yahoo Finance 12 Mar 2024

In this article, we will take a detailed look at 14 Stocks With Heavy Insider Buying In 2024. For...

Insider Monkey via Yahoo Finance 29 Feb 2024

Christopher Morabito, Chief Medical Officer of Astria Therapeutics Inc (NASDAQ:ATXS), has sold 10...

GuruFocus.com via Yahoo Finance 29 Jan 2024

Investors are always looking for stocks that are poised to beat at earnings season and Astria...

Zacks · via Yahoo Finance 17 Nov 2023

Astria Therapeutics, Inc. (NASDAQ:ATXS) Q3 2023 Earnings Call Transcript November 13, 2023 Astria...

Insider Monkey via Yahoo Finance 14 Nov 2023

<img src=https://s.yimg.com/ny/api/res/1.2/BXjRdIuVECboK1L8TJbV.Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyM...

GuruFocus.com via Yahoo Finance 13 Nov 2023